Keytruda campaigners have greeted the Pharmac's decision to fund the melanoma drug with a mixture of joy, sorrow and hope. After a $39 million boost as part of May's Budget was confirmed, Pharmac proposed to fund rival melanoma drug Opdivo. Today's announcement comes after Pharmac in June published a provisional agreement to fund Keytruda. Fellow Keytruda campaigner and melanoma sufferer Katrina Govorko said Pharmac's decision gave those with melanoma choice. The 47-year-old Tauranga mum also campaigned for the drug to be funded, and said Pharmac's decision had left her with mixed feelings.

Source: New Zealand Herald August 02, 2016 07:10 UTC